Press Releases Oncotelic Therapeutics, Inc.

Equities

OTLC

US6283411097

Delayed OTC Markets Other stock markets 17:49:43 14/05/2024 BST			5-day change	1st Jan Change
0.039 ^USD	+1.17%		+3.72%	+1.83%

04-12	Oncotelic Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
03-25	Oncotelic Therapeutics, Inc. Announces Linkage of Cancer and Lupus in Gliomas Patients	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ONCOTELIC PRESENTING AT BIOPHARMA NEXUS CONFERENCE SAN DIEGO 2024	05-08	AQ
Oncotelic Therapeutics, Inc. to Sell Its Necroptosis Cancer Therapy Assets to Mosaic ImmunoEngineering, Inc.	04-29	AQ
Oncotelic Therapeutics, Inc. - Linkage of Cancer and Lupus in Gliomas Patients	03-26	AQ
Linkage of Cancer and Lupus in Gliomas Patients	03-25	AQ
Invitation to Participate in STOP-PC Clinical Trial	03-04	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2024 (Updated)	02-21	AQ
Oncotelic Therapeutics Announces Clinical Linkage of TGFB2 and IFNGR2 in Pediatric DMG Patients	01-16	AQ
Diffuse Intrinsic Pontine Glioma Pipeline, FDA Approvals, Clinical Trials Developments, and Companies 2023 (Updated)	12-22	AQ
Oncotelic Therapeutics Announces Opening of GMP Manufacturing Plant	12-18	AQ
Oncotelic Therapeutics Announces CEO to Discuss Proprietary AI Technology at Ibero-American Chatbot Summit	11-29	AQ
Oncotelic Therapeutics Announces CEO To Discuss Proprietary AI Technology at Ibero-American Chatbot Summit.	11-28	AQ
Oncotelic Reports Q3 2023 Compared to Q3 2022 Financial Results	11-15	AQ
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	28/08/23	AQ
Oncotelic Therapeutics, Inc. Awarded Top Cancer Immunotherapy Solutions Provider 2023	25/08/23	AQ
Sapu BioScience and Cromos Pharma initiating P201 – A Registrational trial for OT-101 in Pancreatic Cancer	23/08/23	AQ
Four Potentially Undervalued OTC Stocks (DDDX, OTLC, AABB, UNRV)	26/06/23	AQ
Oncotelic Launches PR Chatbot	12/06/23	AQ
Oncotelic Participating at 2023 BIO International Convention	16/05/23	AQ
Oncotelic Launches PDAO SEC Chatbot	24/04/23	AQ
ONCOTELIC THERAPEUTICS, INC. - 10-K/A - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	20/04/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Oncotelic Therapeutics, Inc.

Equities

OTLC

US6283411097

Press Releases

Filters